Terence J. Connors
Known title: DirectorCIK: 0001689279
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
SeekingAlpha Highlights SPH as Safer High‑Dividend Small‑Cap. SeekingAlpha's recent piece labels SPH as a high‑dividend small‑cap, noting its 7.56% yield and P/E of 8.5. The author calls it a safer option among "toy dogs" for October. This highlights SPH’s appeal to income‑focused investors and its position within a narrow 52‑week range.
Transaction History
| AHCO | ▲ Buy | Grant | 18,999 | $0 | 6/24/2026 | View on chart |
| SPH | ▲ Buy | Option Exercise | 2,354 | $44K | 11/14/2025 | View on chart |
| SPH | ▼ Sell | Other | 2,354 | $44K | 11/14/2025 | View on chart |
| AHCO | ▲ Buy | Grant | 21,346 | $0 | 6/26/2025 | View on chart |
| SPH | ▼ Sell | Open Market | 1,500 | $29K | 12/3/2024 | View on chart |
| SPH | ▲ Buy | Grant | 13,112 | $0 | 11/15/2024 | View on chart |
| AHCO | ▲ Buy | Grant | 15,629 | $0 | 6/24/2024 | View on chart |
| AHCO | ▲ Buy | Grant | 15,949 | $0 | 6/22/2023 | View on chart |
| AHCO | ▲ Buy | Grant | 9,321 | $0 | 6/22/2022 | View on chart |
| SPH | ▲ Buy | Grant | 22,316 | $0 | 11/15/2021 | View on chart |
| AHCO | ▲ Buy | Grant | 4,509 | $0 | 8/23/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
AdaptHealth (AHCO) flagged in Yahoo's cautionary stock list
A recent Yahoo article placed AHCO among three stocks that Wall Street should think twice about. The piece suggests investors may need to re‑evaluate expectations for the company. The stock is currently near its long‑term support level of $5.70 and shows a moderate RSI, which aligns with the cautious tone of the article.
AdaptHealth (AHCO) flagged in Yahoo's cautionary stock list. A recent Yahoo article placed AHCO among three stocks that Wall Street should think twice about. The piece suggests investors may need to re‑evaluate expectations for the company. The stock is currently near its long‑term support level of $5.70 and shows a moderate RSI, which aligns with the cautious tone of the article.